Market cap is approximately 409.4 million.
CHTP only has one drug available for commercial use, NORTHERA, so the value, IMO, of NORTHERA at this time is 409.4 million.
CHTP is not equipped to place the drug on the market itself and it is possibly doing one of the following at the moment...
1. Trying to get a buyer for CHTP.
2. Trying to get a partner to commercialize NORTHERA.
3. Trying to get financing to commercialize NROTHERA itself.
#2 should have happened a long time ago, so IMO this is not happening.
#1 will be difficult for CHTP to do as the stock price continues to drops, bc insiders will refuse to sell.
#3 will be difficult for CHTP to do as the stock price drops, because lenders do not like a shrinking market cap.
In any event, something has to happen soon.
If they release another PR that they are working on avenues to bring NORTHERA to market this will drop to pre Jan. 14 price.
